Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Here are five top Goldman Sachs dividend-paying stock picks that investors can buy now and hold for the next decade or longer ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

The first day of flu and COVID shots set a single-day record, with 82,000 shots administered through B.C. pharmacies ...

Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...

Oncosure is proud to introduce a membership plan that makes rapid cancer screening accessible to everyone. With just a simple blood draw, our all-in-one test screens for any type of cancer, detecting ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

Sniff spikes, the study noted, might help researchers better understand some of the mental issues experienced by covid patients who have lost their sense of smell. Separately, researchers found that ...